Eloxx Pharmaceuticals Inc., has appointed Ali Hariri, M.D., as its chief medical officer, overseeing clinical development efforts for the company’s promising pipeline of therapies to treat rare diseases. Dr. Hariri will report to Vijay Modur, M.B.B.S., Ph.D., the company’s head of Research and Development.   Hariri was previously senior global project head in Rare Disease Clinical Development at Sanofi where he oversaw key functions responsible for advancing a number of investigational therapies...